These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 2473764)
21. A suppressor T-lymphocyte cell line for autoimmune encephalomyelitis. Ellerman KE; Powers JM; Brostoff SW Nature; 1988 Jan; 331(6153):265-7. PubMed ID: 2447505 [TBL] [Abstract][Full Text] [Related]
22. Lymphocyte vaccination against experimental autoimmune encephalomyelitis: evaluation of vaccination protocols. Offner H; Jones R; Celnik B; Vandenbark AA J Neuroimmunol; 1989 Jan; 21(1):13-22. PubMed ID: 2521179 [TBL] [Abstract][Full Text] [Related]
23. Administration of agonistic anti-4-1BB monoclonal antibody leads to the amelioration of experimental autoimmune encephalomyelitis. Sun Y; Lin X; Chen HM; Wu Q; Subudhi SK; Chen L; Fu YX J Immunol; 2002 Feb; 168(3):1457-65. PubMed ID: 11801689 [TBL] [Abstract][Full Text] [Related]
24. Pathogenic and non-pathogenic T lymphocytes specific for the encephalitogenic epitope of myelin basic protein: functional characteristics and vaccination properties. Beraud E; Balzano C; Zamora AJ; Varriale S; Bernard D; Ben-Nun A J Neuroimmunol; 1993 Aug; 47(1):41-53. PubMed ID: 7690770 [TBL] [Abstract][Full Text] [Related]
25. Analysis of V beta 8.2 CDR3 sequences from spinal cord T cells of Lewis rats vaccinated or treated with TCR V beta 8.2-39-59 peptide. Buenafe AC; Vainiene M; Celnik B; Vandenbark AA; Offner H J Immunol; 1995 Aug; 155(3):1556-64. PubMed ID: 7636217 [TBL] [Abstract][Full Text] [Related]
26. Clonal diversity of basic protein specific T cells in Lewis rats recovered from experimental autoimmune encephalomyelitis. Vainiene M; Offner H; Morrison WJ; Wilkinson M; Vandenbark AA J Neuroimmunol; 1991 Sep; 33(3):207-16. PubMed ID: 1714918 [TBL] [Abstract][Full Text] [Related]
27. Inactivation of T cell receptor peptide-specific CD4 regulatory T cells induces chronic experimental autoimmune encephalomyelitis (EAE). Kumar V; Stellrecht K; Sercarz E J Exp Med; 1996 Nov; 184(5):1609-17. PubMed ID: 8920851 [TBL] [Abstract][Full Text] [Related]
28. Curcumin inhibits experimental allergic encephalomyelitis by blocking IL-12 signaling through Janus kinase-STAT pathway in T lymphocytes. Natarajan C; Bright JJ J Immunol; 2002 Jun; 168(12):6506-13. PubMed ID: 12055272 [TBL] [Abstract][Full Text] [Related]
29. Characterization of basic protein-specific T cell lines selected from Lewis rats with relapsing experimental autoimmune encephalomyelitis. Bourdette DN; Turner MJ; Vandenbark AA; Offner H J Neuroimmunol; 1990 Jan; 26(1):81-5. PubMed ID: 1688445 [TBL] [Abstract][Full Text] [Related]
30. CXCL10 (IFN-gamma-inducible protein-10) control of encephalitogenic CD4+ T cell accumulation in the central nervous system during experimental autoimmune encephalomyelitis. Fife BT; Kennedy KJ; Paniagua MC; Lukacs NW; Kunkel SL; Luster AD; Karpus WJ J Immunol; 2001 Jun; 166(12):7617-24. PubMed ID: 11390519 [TBL] [Abstract][Full Text] [Related]
31. Acquired tolerance to experimental autoimmune encephalomyelitis by intrathymic injection of myelin basic protein or its major encephalitogenic peptide. Khoury SJ; Sayegh MH; Hancock WW; Gallon L; Carpenter CB; Weiner HL J Exp Med; 1993 Aug; 178(2):559-66. PubMed ID: 7688026 [TBL] [Abstract][Full Text] [Related]
32. Vaccination against experimental autoimmune diseases using T lymphocytes treated with hydrostatic pressure. Lider O; Shinitzky M; Cohen IR Ann N Y Acad Sci; 1986; 475():267-73. PubMed ID: 2431645 [No Abstract] [Full Text] [Related]
33. Regulation of the effector stages of experimental autoimmune encephalomyelitis via neuroantigen-specific tolerance induction. Kennedy MK; Tan LJ; Dal Canto MC; Miller SD J Immunol; 1990 Jul; 145(1):117-26. PubMed ID: 2358669 [TBL] [Abstract][Full Text] [Related]
34. Attenuated T-lymphocyte lines as vaccinating agents against experimental autoimmune encephalomyelitis. Offner H; Jones R; Vandenbark AA Ann N Y Acad Sci; 1988; 540():540-2. PubMed ID: 2462830 [No Abstract] [Full Text] [Related]
35. Synergy between encephalitogenic T cells and myelin basic protein-specific antibodies in the induction of experimental autoimmune encephalomyelitis. Myers KJ; Sprent J; Dougherty JP; Ron Y J Neuroimmunol; 1992 Nov; 41(1):1-8. PubMed ID: 1281165 [TBL] [Abstract][Full Text] [Related]
36. Adoptive transfer of experimental allergic encephalomyelitis: conditions influencing memory and effector cell development. Bouwer HG; Dietsch GN; Hinrichs DJ Cell Immunol; 1990 Nov; 131(1):219-31. PubMed ID: 1699673 [TBL] [Abstract][Full Text] [Related]
37. Inhibition of allergic encephalomyelitis in marmosets by vaccination with recombinant vaccinia virus encoding for myelin basic protein. Genain CP; Gritz L; Joshi N; Panicali D; Davis RL; Whitaker JN; Letvin NL; Hauser SL J Neuroimmunol; 1997 Nov; 79(2):119-28. PubMed ID: 9394784 [TBL] [Abstract][Full Text] [Related]
38. The Wistar Kyoto (RT1(l)) rat is resistant to myelin basic protein-induced experimental autoimmune encephalomyelitis: comparison with the susceptible Lewis (RT1(l)) strain with regard to the MBP-directed CD4+ T cell repertoire and its regulation. Stevens DB; Gold DP; Sercarz EE; Moudgil KD J Neuroimmunol; 2002 May; 126(1-2):25-36. PubMed ID: 12020954 [TBL] [Abstract][Full Text] [Related]
39. Lymphokine mRNA expression in the spinal cords of Lewis rats with experimental autoimmune encephalomyelitis is associated with a host recruited CD45R hi/CD4+ population during recovery. Weinberg AD; Wyrick G; Celnik B; Vainiene M; Bakke A; Offner H; Vandenbark AA J Neuroimmunol; 1993 Oct; 48(1):105-17. PubMed ID: 7693749 [TBL] [Abstract][Full Text] [Related]